胃食管反流病患者使用质子泵抑制剂与胃癌风险之间的关联。 - Suppr

Suppr

超能文献

Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.

作者信息

Peng Yen-Chun, Huang Lam-Ru, Lin Cheng-Li, Hsu Wan-Yun, Chang Chi-Sen, Yeh Hong-Zen, Kao Chia-Hung

机构信息

Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

National Yang-Ming University, Taipei, Taiwan.

出版信息

Gut. 2019 Feb;68(2):374-376. doi: 10.1136/gutjnl-2018-316057. Epub 2018 Feb 22.

DOI:10.1136/gutjnl-2018-316057

PMID:29472295

Abstract

摘要

相似文献

Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.胃食管反流病患者使用质子泵抑制剂与胃癌风险之间的关联。

Gut. 2019 Feb;68(2):374-376. doi: 10.1136/gutjnl-2018-316057. Epub 2018 Feb 22.

CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms.CYP2C19药物遗传学在质子泵抑制剂治疗胃食管反流病临床应用中的研究：变异等位基因可预测胃酸抑制情况，但无法预测食管酸暴露或反流症状。

Aliment Pharmacol Ther. 2003 Jun 15;17(12):1521-8. doi: 10.1046/j.1365-2036.2003.01645.x.

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.睡前服用H2阻滞剂可改善服用质子泵抑制剂的胃食管反流病患者的夜间胃酸控制情况。

Aliment Pharmacol Ther. 2001 Sep;15(9):1351-6. doi: 10.1046/j.1365-2036.2001.01050.x.

Helicobacter pylori: a debated factor in gastroesophageal reflux disease.幽门螺杆菌：胃食管反流病中一个存在争议的因素。

Dig Dis. 2001;19(2):127-33. doi: 10.1159/000050667.

Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.质子泵抑制剂治疗期间夜间胃酸突破相关的胃食管反流

Aliment Pharmacol Ther. 1998 Dec;12(12):1231-4. doi: 10.1046/j.1365-2036.1998.00419.x.

Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.胃食管反流病（GERD）患者的夜间胃酸突破与夜间胃食管反流无关。

Dig Dis. 2009;27(1):68-73. doi: 10.1159/000210107. Epub 2009 May 8.

GERD: increased gastric acid secretion as a possible cause of GERD.胃食管反流病（GERD）：胃酸分泌增加可能是胃食管反流病的一个病因。

Nat Rev Gastroenterol Hepatol. 2010 Mar;7(3):125-6. doi: 10.1038/nrgastro.2009.240.

Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.综述文章：胃食管反流病管理中的抑酸治疗——基层医疗中治疗方案的评估

Aliment Pharmacol Ther. 2001 Jun;15(6):765-72. doi: 10.1046/j.1365-2036.2001.00985.x.

Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.在一例无幽门螺杆菌感染病史的病例中，胃增生性息肉与质子泵抑制剂的使用相关。

Intern Med. 2017;56(14):1825-1829. doi: 10.2169/internalmedicine.56.8040. Epub 2017 Jul 15.

Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.胃溃疡患者中针对质子泵抑制剂反跳效应进行抑酸及既往幽门螺杆菌根除治疗的必要性：一项随机前瞻性研究

Hepatogastroenterology. 2009 May-Jun;56(91-92):624-8.

引用本文的文献

A meta-analysis of the effects of proton pump inhibitors on the risk of gastric cancer.质子泵抑制剂对胃癌风险影响的荟萃分析。

Medicine (Baltimore). 2025 Jul 11;104(28):e43053. doi: 10.1097/MD.0000000000043053.

Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective.质子泵抑制剂与胃癌风险：一项系统综述、证据综合及生命历程流行病学视角分析

BMJ Open Gastroenterol. 2025 Apr 19;12(1):e001719. doi: 10.1136/bmjgast-2024-001719.

Association of Proton Pump Inhibitor Use With Gastric Cancer in Regions With High Prevalence of Gastric Cancer: Systematic Review and Meta-analysis.胃癌高发地区质子泵抑制剂使用与胃癌的关联：系统评价与荟萃分析

J Neurogastroenterol Motil. 2025 Apr 30;31(2):178-185. doi: 10.5056/jnm24145.

Multiple metachronous foveolar-type gastric adenomas in a Helicobacter pylori-naïve patient with long-term use of a proton pump inhibitor: a case report.一名长期使用质子泵抑制剂且未感染幽门螺杆菌的患者发生多灶性同期小凹型胃腺瘤：病例报告

Gastric Cancer. 2025 May;28(3):537-543. doi: 10.1007/s10120-025-01595-w. Epub 2025 Feb 13.

The central role of gastrin in gastric cancer.胃泌素在胃癌中的核心作用。

Front Oncol. 2023 Oct 24;13:1176673. doi: 10.3389/fonc.2023.1176673. eCollection 2023.

Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.长期使用质子泵抑制剂的患者患胃癌的风险：观察性和干预性研究的系统评价和荟萃分析。

Dig Dis Sci. 2023 Sep;68(9):3732-3744. doi: 10.1007/s10620-023-08018-9. Epub 2023 Jul 11.

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis.随机临床试验：评估 vonoprazan 作为糜烂性食管炎患者维持治疗的长期安全性的 VISION 试验的 3 年中期分析结果。

BMC Gastroenterol. 2023 May 1;23(1):139. doi: 10.1186/s12876-023-02772-w.

Use of proton pump inhibitors for the risk of gastric cancer.质子泵抑制剂用于胃癌风险。

Medicine (Baltimore). 2022 Dec 9;101(49):e32228. doi: 10.1097/MD.0000000000032228.

The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis.质子泵抑制剂对自身免疫性萎缩性胃炎患者胃肿瘤性病变发展的影响。

Front Immunol. 2022 Jul 22;13:910077. doi: 10.3389/fimmu.2022.910077. eCollection 2022.

Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal.质子泵抑制剂的使用与胃癌风险：来自流行病学研究的当前证据及批判性评价

Cancers (Basel). 2022 Jun 21;14(13):3052. doi: 10.3390/cancers14133052.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验